Table 2.
Operative details, outcomes, and complications.
| n (%) | n (%) | ||
|---|---|---|---|
| Operative characteristics | Operative outcomes | ||
| Surgical service | COVID-related inability to extubate in OR | 3 (7.7%) | |
| Trauma | 3 (7.7%) | New postoperative COVID-related ICU requirement | 7 (17.9%) |
| General | 8 (20.5%) | Postoperative ICU length of stay (days)∗ | 7.7 ± 4.1 |
| Cardiothoracic/interventional cardiology | 4 (10.3%) | Respiratory support | |
| Vascular | 4 (10.3%) | Supplemental oxygen | 9 (23.1%) |
| Orthopedic/hand | 8 (20.5%) | CPAP/BiPAP | 1 (2.6%) |
| Neurosurgery | 4 (10.3%) | Intubation | 5 (13.2%) |
| Plastic/OMFS | 3 (7.7%) | Extubated | 3 (60%) |
| Pediatric | 2 (5.1%) | Days on ventilator∗ | 10.2 ± 3.3 |
| OB-Gyn | 1 (2.6%) | COVID-related severe complications | |
| Podiatry | 2 (5.1%) | ARDS | 5 (12.8%) |
| ASA classification | Shock requiring pressors | 6 (15.4%) | |
| 1 | 4 (10.3%) | Acute kidney injury | 6 (15.4%) |
| 2 | 12 (30.8%) | New dialysis requirement | 0 |
| 3 | 15 (38.5%) | ECMO | 0 |
| 4 | 8 (20.5%) | Pulmonary embolism | 0 |
| Procedure length (mins)∗ | 177.3 ± 115.1 | Deep venous thrombosis | 0 |
| Type of anesthesia | Other ischemic or thrombotic complication | 1 (2.6%) | |
| General | 35 (89.7%) | Secondary infection | 5 (13.2%) |
| IV sedation/local | 4 (10.3%) | Disposition | |
| Airway management | Hospital length of stay (days)∗ | 20.9 ± 29.1 | |
| Endotracheal tube | 34 (87.2%) | Discharged from hospital | 26 (66.7%) |
| Laryngeal mask airway | 2 (5.1%) | Remain admitted to hospital | 9 (23.1%) |
| Nasal cannula oxygen or N/A | 3 (7.7%) | Deceased | 4 (10.3%) |
ASA = American Society of Anesthesiologists.
∗
Mean ± Standard Deviation.